Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis
Clinical Endocrinology · 2026-08 · 105 (2) · 237-244
DOI: 10.1111/cen.70140 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Endocrinology, online erschienen am 07.04.2026. Verfasst von Daniele Tienforti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Andrology Unit, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Inositol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effect of inositol supplementation on biochemical hyperandrogenism in women with polycystic ovary syndrome (PCOS) and to explore whether metabolic phenotype modifies the endocrine response.
Design
Systematic review and meta‐analysis of randomized controlled trials conducted in accordance with PRISMA guidelines. Patients Women diagnosed with PCOS according to established criteria (NIH, Rotterdam, or AE‐PCOS). Nine eligible trials comprising a total of 440 participants were included.
Measurements
Primary outcomes were serum total testosterone (TT), calculated free testosterone (cFT), free androgen index (FAI), and sex hormone–binding globulin (SHBG). Prespecified subgroup analyses explored differences according to body mass index (BMI) and insulin resistance (HOMA‐IR).
Results
Inositol supplementation was associated with significant reductions in TT (SMD –1.30; 95% CI –2.17 to –0.42), cFT, and FAI, together with an increase in SHBG. Substantial heterogeneity was observed for several outcomes. In subgroup analyses, the largest and most consistent reduction in TT was observed among normal‐weight women (BMI < 25 kg/m²) (SMD –2.97; 95% CI –3.78 to –2.16), with minimal heterogeneity ( I ² = 9%). No significant improvements were detected in overweight or obese women, nor in women with insulin resistance when considered independently of BMI. These subgroup findings should be interpreted as exploratory.
Conclusions
Inositol supplementation is associated with improvements in biochemical hyperandrogenism in women with PCOS, with evidence of phenotype‐dependent variability. The most consistent biochemical response was observed in normal‐weight individuals. These findings support a metabolically informed, hypothesis‐generating framework and highlight the need for adequately powered, phenotype‐stratified trials incorporating clinically meaningful outcomes, including standardized measures of hirsutism, ovulatory function, and patient‐reported endpoints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Andrology Unit, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
ORCID-Profile: Daniele Tienforti
Zitieren
APA
Tienforti, D., Puocci, G., Venditti, C., Gizzi, V., Pisanò, C., Cocci, E., Perfetto, E., D'Alessandro, F., Spagnolo, L., Baroni, M. G., & Barbonetti, A. (2026). Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis. Clinical Endocrinology, 105(2), 237-244. https://doi.org/10.1111/cen.70140
Vancouver
Tienforti D, Puocci G, Venditti C, Gizzi V, Pisanò C, Cocci E, et al. Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis. Clinical Endocrinology. 2026;105(2):237-244. doi:10.1111/cen.70140
BibTeX
@article{Tienforti2026,
author = {Tienforti, Daniele and Puocci, Gennaro and Venditti, Claudia and Gizzi, Valentina and Pisanò, Carlo and Cocci, Elisa and Perfetto, Elisabetta and D'Alessandro, Francesco and Spagnolo, Luca and Baroni, Marco Giorgio and Barbonetti, Arcangelo},
title = {Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis},
journal = {Clinical Endocrinology},
year = {2026},
volume = {105},
number = {2},
pages = {237--244},
doi = {10.1111/cen.70140}
}
EUVIMED